These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 748781

  • 21. Antiproliferative and antimetastatic effects of gossypol on Dunning prostate cell-bearing Copenhagen rats.
    Chang CJ, Ghosh PK, Hu YF, Brueggemeier RW, Lin YC.
    Res Commun Chem Pathol Pharmacol; 1993 Mar; 79(3):293-312. PubMed ID: 8480076
    [Abstract] [Full Text] [Related]

  • 22. Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis.
    Wong SY, Haack H, Crowley D, Barry M, Bronson RT, Hynes RO.
    Cancer Res; 2005 Nov 01; 65(21):9789-98. PubMed ID: 16267000
    [Abstract] [Full Text] [Related]

  • 23. Biochemical methods for predicting metastatic ability of prostatic cancer utilizing the dunning R-3327 rat prostatic adenocarcinoma system as a model.
    Lowe FC, Isaacs JT.
    Cancer Res; 1984 Feb 01; 44(2):744-52. PubMed ID: 6537899
    [Abstract] [Full Text] [Related]

  • 24. The effect of castanospermine on the metastatic properties of prostate cancer cells.
    Yee CS, Schwab ED, Lehr JE, Quigley M, Pienta KJ.
    Anticancer Res; 1997 Feb 01; 17(5A):3659-63. PubMed ID: 9413219
    [Abstract] [Full Text] [Related]

  • 25. Transplantable metastasizing prostate adenocarcinomas in rats.
    Pollard M, Luckert PH.
    J Natl Cancer Inst; 1975 Mar 01; 54(3):643-9. PubMed ID: 1123852
    [Abstract] [Full Text] [Related]

  • 26. Systemic interleukin 2 therapy for human prostate tumors in a nude mouse model.
    Triest JA, Grignon DJ, Cher ML, Kocheril SV, Montecillo EJ, Talati B, Tekyi-Mensah S, Pontes JE, Hillman GG.
    Clin Cancer Res; 1998 Aug 01; 4(8):2009-14. PubMed ID: 9717832
    [Abstract] [Full Text] [Related]

  • 27. Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma.
    Neri A, Welch D, Kawaguchi T, Nicolson GL.
    J Natl Cancer Inst; 1982 Mar 01; 68(3):507-17. PubMed ID: 6950180
    [Abstract] [Full Text] [Related]

  • 28. Susceptibility of Lobund-Wistar x Copenhagen hybrid rats to autochthonous prostate carcinogenesis.
    Suckow MA, Wolter W, Pollard M.
    Prostate; 2005 Jul 01; 64(2):203-8. PubMed ID: 15712219
    [Abstract] [Full Text] [Related]

  • 29. Concepts in prostatic cancer biology: Dunning R-3327 H, HI, and AT tumors.
    Isaacs JT, Weissman RM, Coffey DS, Scott WW.
    Prog Clin Biol Res; 1980 Jul 01; 37():311-23. PubMed ID: 7384091
    [Abstract] [Full Text] [Related]

  • 30. Isolation and characterization of a cloned cell line R3327H-G8-A1 derived from the dunning R3327H rat adenocarcinoma.
    Sestili MA, Norris JS, Smith RG.
    Cancer Res; 1983 May 01; 43(5):2167-75. PubMed ID: 6299542
    [Abstract] [Full Text] [Related]

  • 31. The Nb rat: prostatic adenocarcinoma model.
    Drago JR, Ikeda RM, Maurer RE, Goldman LB, Tesluk H.
    Invest Urol; 1979 Mar 01; 16(5):353-9. PubMed ID: 429131
    [Abstract] [Full Text] [Related]

  • 32. Improved metastatic animal model of human prostate carcinoma using surgical orthotopic implantation (SOI).
    Chang XH, Fu YW, Na WL, Wang J, Sun H, Cai L.
    Anticancer Res; 1999 Mar 01; 19(5B):4199-202. PubMed ID: 10628375
    [Abstract] [Full Text] [Related]

  • 33. Rat prostate adenocarcinoma cells disseminate to bone and adhere preferentially to bone marrow-derived endothelial cells.
    Haq M, Goltzman D, Tremblay G, Brodt P.
    Cancer Res; 1992 Sep 01; 52(17):4613-9. PubMed ID: 1511429
    [Abstract] [Full Text] [Related]

  • 34. Effect of nucleoside analogue BCH-4556 on prostate cancer growth and metastases in vitro and in vivo.
    Rabbani SA, Harakidas P, Bowlin T, Attardo G.
    Cancer Res; 1998 Aug 01; 58(15):3461-5. PubMed ID: 9699681
    [Abstract] [Full Text] [Related]

  • 35. Metastatic potential and substrate dependence of cell motility and attachment in the Dunning R-3327 rat prostatic adenocarcinoma model.
    Mohler JL, Levy F, Sharief Y.
    Cancer Res; 1991 Dec 15; 51(24):6580-5. PubMed ID: 1742730
    [Abstract] [Full Text] [Related]

  • 36. The Src-suppressed C kinase substrate, SSeCKS, is a potential metastasis inhibitor in prostate cancer.
    Xia W, Unger P, Miller L, Nelson J, Gelman IH.
    Cancer Res; 2001 Jul 15; 61(14):5644-51. PubMed ID: 11454719
    [Abstract] [Full Text] [Related]

  • 37. The presence of prostate-specific antigen-related genes in primates and the expression of recombinant human prostate-specific antigen in a transfected murine cell line.
    Karr JF, Kantor JA, Hand PH, Eggensperger DL, Schlom J.
    Cancer Res; 1995 Jun 01; 55(11):2455-62. PubMed ID: 7538903
    [Abstract] [Full Text] [Related]

  • 38. Metastatic prostate cancer in a transgenic mouse.
    Gingrich JR, Barrios RJ, Morton RA, Boyce BF, DeMayo FJ, Finegold MJ, Angelopoulou R, Rosen JM, Greenberg NM.
    Cancer Res; 1996 Sep 15; 56(18):4096-102. PubMed ID: 8797572
    [Abstract] [Full Text] [Related]

  • 39. Metastasis-enhancing effect of heparin and its relationship to a lipoprotein factor.
    Chan SY, Pollard M.
    J Natl Cancer Inst; 1980 May 15; 64(5):1121-5. PubMed ID: 6929014
    [Abstract] [Full Text] [Related]

  • 40. Novel syngeneic pseudo-orthotopic prostate cancer model: vascular, mitotic and apoptotic responses to castration.
    Frost GI, Lustgarten J, Dudouet B, Nyberg L, Hartley-Asp B, Borgström P.
    Microvasc Res; 2005 Jan 15; 69(1-2):1-9. PubMed ID: 15797254
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.